Target intelligence / Profile preview

Bacterial ribosomal 30S A-site (30S A-site)

Target
30S A-site
Molecular classification
Ribosome, RNA-protein complex, Translation machinery, Other (target site for antibiotics)
01

Overview

The bacterial ribosomal 30S A-site is a region in the small (30S) subunit of the prokaryotic ribosome responsible for the initial selection and binding of aminoacyl-tRNA during translation. The A-site, located within the complex of 16S ribosomal RNA and associated proteins, ensures decoding accuracy by monitoring base pairing between the mRNA codon and the tRNA anticodon. Universal residues in 16S rRNA (such as A1492 and A1493) play critical roles in this process. The 30S A-site is a major target for several classes of antibiotics, notably aminoglycosides and spectinomycin, which bind to this region and disrupt normal translational fidelity, thereby inhibiting bacterial protein synthesis. Mutations in A-site constituents can confer resistance to these drugs, presenting a clinical challenge and motivating ongoing antibiotic development[1][2][3][4][5].

Other names
Prokaryotic ribosomal small subunit A-site30S decoding siteRibosomal A-site
02

Mechanism of action

Interference with decoding by stabilizing erroneous tRNA–mRNA pairing. Disruption of translocation and fidelity mechanisms in protein synthesis. Binding to specific rRNA residues (notably 16S RNA nucleotides A1492, A1493, G530).

03

Biological functions

Protein synthesis (translation)mRNA decoding (ensuring correct pairing of tRNA anticodon and mRNA codon)Fidelity monitoring (discriminating against incorrect tRNAs)
04

Disease associations

Infection (targeted by antibiotics against bacteria)
05

Safety considerations

Toxicity of aminoglycosides (ototoxicity, nephrotoxicity in humans)Bacterial resistance (mutations in ribosomal RNA reduce antibiotic efficacy)Selectivity (potential off-target effects due to similarity with mitochondrial ribosome)
06

Interacting drugs

Aminoglycosides (e.g., paromomycin, streptomycin, gentamycin)

2 more in the full profile.

07

Biomarkers

Mutations in 16S rRNA (esp. A-site residues, such as A1492, A1493, G530) confer antibiotic resistance and alter drug binding

Beyond the preview

Go deeper on Bacterial ribosomal 30S A-site (30S A-site).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial ribosomal 30S A-site (30S A-site).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call